Post by mango on Jan 17, 2019 15:55:04 GMT -5
Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths
Inhalation would also be a safe and effective alternative when there is poor venous access, which is common in IV drug users. Would be great to have in the pre-hospital setting and also in EDs.
Also would significantly reduce undesirable side effects associated with other ROA, and allow for ultra-rapid onset that can be self-administered.
www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629571.htm
Review of nebulzed naloxone:
epmonthly.com/article/nebulized-naloxone-for-acute-opioid-overdose/
Inhalation would also be a safe and effective alternative when there is poor venous access, which is common in IV drug users. Would be great to have in the pre-hospital setting and also in EDs.
Also would significantly reduce undesirable side effects associated with other ROA, and allow for ultra-rapid onset that can be self-administered.
www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629571.htm
Review of nebulzed naloxone:
epmonthly.com/article/nebulized-naloxone-for-acute-opioid-overdose/
